Industrial robot arms are multi-axis articulated machines (typically 4-7 axes of motion) bolted to factory floors to weld, paint, assemble, palletize, and handle materials. Cobots (collaborative robots) are a lighter, force-limited variant designed to work alongside humans without safety cages. In 2024, global factories installed 542,000 industrial robots -- the second-highest year on record, more than double the ~271,000 installed a decade earlier. The operational stock (robots working in factories worldwide) reached 4.66 million units, up 9% year-over-year. Cobots are roughly 8% of annual installations by volume, growing faster than traditional arms. The hardware market was approximately $17.8B in 2024. est. The top three OEMs -- FANUC, ABB, and Yaskawa -- hold a combined ~47.5% global share.
Four tickers give exposure in three ways: FANUC (FANUY) and ABB sell robot arms; Rockwell Automation (ROK) sells motion-control infrastructure (servo drives, PLCs, software) that integrates with robots but does not make arms; Intuitive Surgical (ISRG) makes surgical robots -- a categorically different product (hospitals, not factories) included as the highest-margin robotics business in public markets.
Installations exceeded 500K for four straight years (2021-2024). China installed 295K in 2024 -- a record -- with domestic OEMs outselling foreign brands for the first time (57% share vs. ~28% a decade ago). Outside China, 2024 fell: Japan -4%, US -9%, Germany -5%, Europe -8%. IFR projects >700K by 2028, ~9% CAGR.
IFR World Robotics 2025 (Sep 2025); GM Insights Industrial Robotics Market (2024).
A factory buys a robot arm ($30K-$100K+ depending on payload/axes), controller, teach pendant, and tooling -- total installed cost often $50K-$150K per cell. est. Cobots cost $20K-$50K with lower install costs (no safety caging). The OEM earns the hardware sale upfront, then recurring revenue from spare parts, service contracts, and software.
FANUC (FANUY): Three segments -- Factory Automation (CNC), Robot (~35-40% of revenue est.), Robomachine. FY2025 (ending Mar 2025): ¥857.8B (~$5.7B) consolidated, ¥183.8B operating income (21.4% margin). 1M+ cumulative robots since 1974. FY2026 guidance: ¥909.6B (+6%), 23.3% margin.
ABB: Robotics & Discrete Automation: $2.3B (2024), 7% of $32.9B group, 12.1% EBITA. #2 OEM globally. Spinning off as "ABB Robotics," target Q2 2026; ~7,000 employees; manufacturing in Sweden, China, US.
ROK: Not a robot OEM. PLCs, servo drives, motion controllers, software. $8.26B FY2024 (Sep year-end), down 8.8% (destocking). TTM Mar 2026: $11.1B, +11%. No robotics breakout.
ISRG: Da Vinci surgical robots. Different market (healthcare), customer (hospitals), economics. Systems $1-2.5M; real revenue is razor-blade instruments ($800-$3,500/procedure). Instruments & accessories: $5.08B of $8.35B FY2024 (61%). FY2025: $10.06B (+20.5%). 9,902 installed systems (+15%). Procedure growth 17% (2024).
FANUC FY2025 (Apr 2026); ABB Q4 2024; ROK FY2024 10-K; ISRG FY2024/FY2025 earnings.
Industrial robots are project-ordered on timelines of weeks to months. No multi-year contracted backlog exists. IFR tracks installations ex post.
| Year | Global installs | YoY |
|---|---|---|
| 2021 | ~517,000 | -- |
| 2022 | ~553,000 | +7% |
| 2023 | ~541,000 | -2% |
| 2024 | 542,000 | flat |
By country (2024): China 295K (54%, record), Japan 44.5K (-4%), US 34.2K (-9%), S. Korea 30.6K (-3%), Germany 27K (-5%), India 9.1K (+7%, record). Asia 74%, Europe 16% (-8%), Americas 9% (-10%). Automotive is the largest end-user; electronics ($5.39B, 2024) the fastest-growing.
ISRG (surgical, separate market): 493 systems placed Q4 2024 (+19%). Installed base 9,902 (+15%). Procedure growth 17%. ~5% of surgeries globally use robots. est.
IFR: 575K in 2025 (+6%), >700K by 2028. China ~10%/yr through 2028. GM Insights: $17.8B → $60.1B by 2034, 13.3% CAGR. est.
Two structural expanders: (1) cobots opening the SMB market ($20K-$50K, no caging -- share from ~0% in 2015 to ~8%); (2) AI-driven programming (natural language, learning from demonstration) removing the largest barrier -- weeks of specialized programming per task.
ISRG 2025 guidance: 13-16% procedure growth (vs. 17% in 2024). Gross margin guided 67-68% (vs. 69.1%), partly da Vinci 5 ramp. est.
IFR (Sep 2025); GM Insights (2024); ISRG FY2024/FY2025 earnings.
Big Four (FANUC, ABB, Yaskawa, KUKA) plus Chinese domestics have capacity above current demand. FANUC's Japanese factories: highly automated, 1M+ cumulative units. ABB: regional manufacturing in Sweden/China/US, ~7K robotics employees. Chinese OEMs (Siasun, Estun, JAKA, Dobot) now supply 57% of China's domestic installations.
Cobots: Universal Robots (Teradyne/TER subsidiary) leads. UR revenue $293M (2024), flat. Combined Teradyne robotics (UR + MiR): $365M, 13% operating loss. OEM channel +20%.
Robot arm supply is not constrained. 542K in 2024 was 2% below the 2022 peak -- demand softness, not supply limits. Lead times: 4-12 weeks.
If demand surges, the bottleneck shifts upstream: harmonic drives (Harmonic Drive Systems, ~60% share, 12-18 month lead times), cycloidal reducers (Nabtesco, ~60%), high-precision servos. The arm scales; the gearbox in each joint does not.
ISRG (surgical): constrained by FDA (years), surgeon training, hospital capex. ~80%+ share. est. Competitors 3-5 years behind.
IFR; FANUC FY2025; ABB Q1 2025; Teradyne Q4 2024; ISRG Q4 2024.
| Measure | Demand | Supply |
|---|---|---|
| 2024 installations | 542K | Capacity above -- OEMs had idle lines |
| 2025 forecast | 575K (+6%) | No new capacity needed |
| 2028 forecast | >700K | Incremental expansion sufficient |
| Cobots | ~8%, growing | No shortage |
| Pricing -- arms | Flat to declining; Chinese OEMs compressing ASPs | |
| Pricing -- cobots | Declining (JAKA, Dobot, Aubo competing on price) | |
| Pricing -- surgical | Stable-to-rising; near-monopoly, per-procedure instruments | |
Industrial robots: demand-constrained, not supply-constrained. OEMs can produce more than buyers order. Prices flat-to-declining under Chinese competition. FANUC robot revenue fell 16% in the first nine months of FY ending Mar 2025 -- ordering weakness, not production limits. ABB orders recovering from trough, below peak.
Could invert if AI-driven programming removes the deployment bottleneck or if humanoid production surges demand for shared precision components. Constraint then shifts to harmonic drives and bearings.
ISRG: demand exceeds hospital budgets; regulatory barriers limit competitive supply. 69% gross margins.
IFR; FANUC FY2025; ABB Q1 2025; ISRG 2025 guidance.
| Ticker | Company | Sells | Mkt cap | Rev. | Robotics | Margin | Key |
|---|---|---|---|---|---|---|---|
| ABB | ABB Ltd | Arms, cobots, AMRs + electr./motion/process | $196B | $32.9B | $2.3B (7%) | 12.1% | #2 OEM. Robotics spinoff Q2 2026. |
| FANUY | FANUC (ADR) | Arms, CNC, robomachines | $46.5B | ~$5.7B | ~$2-2.3B est. | 21.4% | #1 OEM. 1M+ units. OTC. |
| ROK | Rockwell Auto. | PLCs, servos, software -- NOT arms | $51.4B | $11.1B TTM | n/a | ~19-20% | US controls. Adjacent. |
| ISRG | Intuitive Surg. | Surgical systems, instruments, service | $144B | $10.06B | $10.06B | ~35% | 9,902 systems. 80%+ share. est. Healthcare. |
ABB and FANUC compete in the same ~$17.8B industrial market. est. FANUC's margin (~21%) is nearly double ABB robotics (12.1%). ROK sells adjacent infrastructure. ISRG is a different market: near-monopoly, regulatory moat, 69% gross margins vs. ~30% for industrial OEMs. est.
ABB Q4 2024; FANUC FY2025; ROK FY2024; ISRG FY2025; stockanalysis.com (Jun 3, 2026).
| Ticker | Price | Mkt cap | P/E | Rev. | P/Rev | Robotics % |
|---|---|---|---|---|---|---|
| ABB | $107.79 | $196B | ~38× | $32.9B | 6.0× | 7% |
| FANUY | $24.82 | $46.5B | 44× | ~$5.7B | 8.2× | ~35-40% est. |
| ROK | $461.73 | $51.4B | ~53× | $11.1B TTM | 4.6× | n/a |
| ISRG | $407.29 | $144B | 49× | $10.06B | 14.3× | 100% |
Implied robotics at ABB: $2.3B revenue at the group's ~6× = ~$14B (7% of $196B cap). At FANUC's ~8× = ~$19B. Spinoff will set its own price.
FANUC: $46.5B for #1 OEM at ~8× rev, 44× earnings. ~35-40% robot, rest CNC + robomachine. Margin 21.4%, guiding 23.3%.
ROK: $51.4B at ~53× trailing. Revenue rebounding (TTM $11.1B vs. $8.26B FY2024). Indirect robotics only.
ISRG: $144B for $10.06B (14.3× rev, 49× earnings). Procedure growth slowing from 17% to guided 13-16%.
stockanalysis.com, companiesmarketcap.com (Jun 3, 2026); filings as cited.
| Source | Covers | Confidence |
|---|---|---|
| IFR World Robotics 2025 (Sep 2025) | 542K installs, countries, 4.66M stock, forecasts | high |
| FANUC FY2025 (Apr 2026) | ¥857.8B rev, 21.4% margin, guidance | high |
| ABB Q4 2024 & spinoff (Apr 2025) | $2.3B robotics, 12.1% EBITA, spinoff | high |
| ROK FY2024 10-K | $8.26B revenue, segments | high |
| ISRG FY2024/FY2025 | $10.06B, 9,902 systems, procedures | high |
| Teradyne Q4 2024 | UR $293M, robotics $365M, -13% | high |
| GM Insights (2024) | $17.78B, $60.1B by 2034, 47.5% top-3 | medium |
| Market data (Jun 3, 2026) | Prices, caps | high |
| Robot pricing ($30K-$100K+, cobots $20K-$50K) | Unit costs | medium |